SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-002249
Filing Date
2020-01-06
Accepted
2020-01-06 16:52:03
Documents
16
Period of Report
2020-01-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d832683d8k.htm   iXBRL 8-K 32794
2 EX-99.1 d832683dex991.htm EX-99.1 5616
3 EX-99.2 d832683dex992.htm EX-99.2 21388
4 EX-99.3 d832683dex993.htm EX-99.3 197346
8 GRAPHIC g832683g71p85.jpg GRAPHIC 123186
  Complete submission text file 0001193125-20-002249.txt   596952

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA itci-20200106.xsd EX-101.SCH 3111
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20200106_lab.xml EX-101.LAB 17373
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20200106_pre.xml EX-101.PRE 10980
14 EXTRACTED XBRL INSTANCE DOCUMENT d832683d8k_htm.xml XML 3214
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 20510511
SIC: 2834 Pharmaceutical Preparations